ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification
暂无分享,去创建一个
S-H Tan | S. Srivastava | I. Sesterhenn | I. Sesterhenn | S. Srivastava | Yongmei Chen | G. Petrovics | D. Mcleod | A. Dobi | G. Mcmaster | Chen Sun | Shyh-Han Tan | T. Sreenath | B. Furusato | S Srivastava | I A Sesterhenn | D G McLeod | C Sun | A Dobi | B Furusato | D Young | A A Mohamed | R Thangapazham | Y Chen | G McMaster | T Sreenath | G Petrovics | D. Young | A. Mohamed | R. Thangapazham | S-H Tan | Y. Chen | C. Sun | Chen Sun | Shyh-Han Tan | Rajesh L. Thangapazham | Gary McMaster
[1] E. Dejana,et al. Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin. , 2008, Blood.
[2] W. Gerald,et al. TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy. , 2009, Cancer research.
[3] Pier Paolo Pandolfi,et al. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate , 2009, Nature Genetics.
[4] P. Nelson,et al. A causal role for ERG in neoplastic transformation of prostate epithelium , 2008, Proceedings of the National Academy of Sciences.
[5] Chen Sun,et al. Delineation of TMPRSS2-ERG Splice Variants in Prostate Cancer , 2008, Clinical Cancer Research.
[6] E. Baldi,et al. Persistence of expression of the TMPRSS2:ERG fusion gene after pre-surgery androgen ablation may be associated with early prostate specific antigen relapse of prostate cancer: Preliminary results , 2009, Journal of endocrinological investigation.
[7] D. Watson,et al. Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin. , 2003, The American journal of pathology.
[8] S. Srivastava,et al. Mapping of TMPRSS2–ERG fusions in the context of multi-focal prostate cancer , 2008, Modern Pathology.
[9] M. Teitell,et al. ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells , 2009, Proceedings of the National Academy of Sciences.
[10] R. Shah,et al. Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases. , 2007, Cancer research.
[11] R. Eeles,et al. Diversity of TMPRSS2-ERG fusion transcripts in the human prostate , 2007, Oncogene.
[12] S. Dhanasekaran,et al. A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer. , 2008, Cancer research.
[13] M. Rubin,et al. TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications. , 2007, Urology.
[14] M. Gerstein,et al. N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer. , 2009, Neoplasia.
[15] C. Sander,et al. Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis , 2009, Nature Genetics.
[16] A. Chinnaiyan,et al. Recurrent gene fusions in prostate cancer , 2008, Nature Reviews Cancer.
[17] Rodrigo Lopez,et al. Clustal W and Clustal X version 2.0 , 2007, Bioinform..
[18] Botoul Maqsodi,et al. Evaluation of the branched-chain DNA assay for measurement of RNA in formalin-fixed tissues. , 2007, The Journal of molecular diagnostics : JMD.
[19] J. Tchinda,et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.
[20] P. Remy,et al. Xl erg: Expression pattern and overexpression during development plead for a role in endothelial cell differentiation , 1999, Developmental dynamics : an official publication of the American Association of Anatomists.
[21] V. Srikantan,et al. Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome , 2005, Oncogene.
[22] S. Srivastava,et al. TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation , 2008, Oncogene.
[23] P. Humphrey,et al. Immunohistochemical Stains for p63 and α-Methylacyl-CoA Racemase, Versus a Cocktail Comprising Both, in the Diagnosis of Prostatic Carcinoma: A Comparison of the Immunohistochemical Staining of 430 Foci in Radical Prostatectomy and Needle Biopsy Tissues , 2005, The American journal of surgical pathology.
[24] I. Kola,et al. Detailed mapping of the ERG-ETS2 interval of human chromosome 21 and comparison with the region of conserved synteny on mouse chromosome 16. , 2004, Gene.
[25] R. Henrique,et al. TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions. , 2006, Neoplasia.
[26] C. Cooper,et al. ETS gene fusions in prostate cancer , 2009, Nature Reviews Urology.
[27] R. Shah,et al. Role of the TMPRSS2-ERG gene fusion in prostate cancer. , 2008, Neoplasia.
[28] M. Rubin,et al. TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion , 2006, The American journal of surgical pathology.
[29] J. Tchinda,et al. TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. , 2006, Cancer research.
[30] Graham J. Lieschke,et al. The role of the ETS factor erg in zebrafish vasculogenesis , 2009, Mechanisms of Development.